BRUNETTI, LEONARDO
 Distribuzione geografica
Continente #
NA - Nord America 809
EU - Europa 313
AS - Asia 205
AF - Africa 3
OC - Oceania 2
SA - Sud America 2
Totale 1.334
Nazione #
US - Stati Uniti d'America 803
IT - Italia 105
SE - Svezia 98
CN - Cina 92
SG - Singapore 80
FR - Francia 27
DE - Germania 26
GB - Regno Unito 23
IN - India 17
BE - Belgio 8
CA - Canada 6
FI - Finlandia 6
VN - Vietnam 5
NL - Olanda 4
CH - Svizzera 3
JP - Giappone 3
PL - Polonia 3
TW - Taiwan 3
AT - Austria 2
AU - Australia 2
CZ - Repubblica Ceca 2
EG - Egitto 2
LT - Lituania 2
TH - Thailandia 2
AR - Argentina 1
BD - Bangladesh 1
BR - Brasile 1
ES - Italia 1
HK - Hong Kong 1
IE - Irlanda 1
KR - Corea 1
MD - Moldavia 1
NG - Nigeria 1
RU - Federazione Russa 1
Totale 1.334
Città #
Chandler 174
Nyköping 96
Fairfield 81
Ashburn 74
Singapore 65
Cambridge 51
Houston 33
Seattle 32
Woodbridge 30
Wilmington 28
New York 24
Beijing 22
Lawrence 21
Roxbury 19
Bari 18
Inglewood 16
Marseille 16
Munich 14
Milan 13
Ann Arbor 12
Naples 12
Boydton 9
Des Moines 9
London 9
Brussels 8
Guangzhou 7
Helsinki 6
Paris 6
Shanghai 6
Wuxi 6
Bitonto 5
Brindisi 5
Dong Ket 5
Los Angeles 5
Patna 5
Rome 5
Santa Clara 5
Shenzhen 5
Salerno 4
Washington 4
West Jordan 4
Wuhan 4
Amsterdam 3
Bhubaneswar 3
Boardman 3
Dearborn 3
Edinburgh 3
Florence 3
Frankfurt am Main 3
Jiaxing 3
Jinhua 3
Kyoto 3
Princeton 3
San Diego 3
Sannicandro di Bari 3
Toronto 3
Warsaw 3
Bokaro 2
Brno 2
Brooklyn 2
Cairo 2
Camerino 2
Chandigarh 2
Crispiano 2
Dalian 2
Falkenstein 2
Geneva 2
Giugliano in Campania 2
Kilburn 2
Lucknow 2
Molfetta 2
Nonthaburi 2
Port Townsend 2
Pune 2
Redwood City 2
San Francisco 2
Taichung 2
Vancouver 2
Biella 1
Brisbane 1
Canberra 1
Castellana Grotte 1
Chengdu 1
Chicago 1
Chisinau 1
Council Bluffs 1
Dhaka 1
Dublin 1
Easton 1
Guwahati 1
Hounslow 1
Jinan 1
Lagoa Santa 1
Lagos 1
Las Vegas 1
Longyan 1
Madrid 1
Monmouth Junction 1
Nanchang 1
New Bedfont 1
Totale 1.082
Nome #
New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) Activation 99
Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease 89
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors 80
A Review of Recent Patents (2016-2019) on Plant Food Supplements with Potential Application in the Treatment of Neurodegenerative and Metabolic Disorders 79
Bone-seeking matrix metalloproteinase inhibitors for the treatment of skeletal malignancy 66
Deep Eutectic Solvents as Effective Reaction Media for the Synthesis of 2‐Hydroxyphenylbenzimidazole-based Scaffolds en Route to Donepezil‐Like Compounds 64
Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents 63
Natural compounds as FAAH inhibitors: preliminary screening and potential developments 60
1,3,5-triazine derivatives as dual inhibitors of 5-HT6R/FAAH in search of new therapy for Alzheimer's disease 54
Identification of Natural Scaffolds as New Multi-Functional Agents for the Treatment of Alzheimer’s Disease 54
Importance of Biometals as Targets in Medicinal Chemistry: An Overview about the Role of Zinc (II) Chelating Agents 53
Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases 48
(2-Aminobenzothiazole)-Methyl-1,1-bisphosphonic acids: Targeting matrix metalloproteinase 13 inhibition to the bone 47
A Chemoinformatics Search for Peroxisome Proliferator-Activated Receptors Ligands Revealed a New Pan-Agonist Able to Reduce Lipid Accumulation and Improve Insulin Sensitivity 46
Novel small molecules for PPARs modulation and their potential use for treatment of metabolic disorders 40
Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease 37
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE) 34
Can foods influence the onset and progress of neurodegenerative diseases? 33
Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σ1) receptor ligands with potent anti-amnesic effect 33
DEVELOPMENT OF PHENOXYALKYLPIPERIDINES AS HIGH-AFFINITY SIGMA-1 (s1) RECEPTOR LIGANDS WITH POTENT ANTI-AMNESIC ACTIVITY 31
Multiple causes, multiple targets: FAAH as a centerpiece for therapy of multifactorial pathologies. 24
A NEW ANTIDIABETIC AGENT SHOWING PPARα/γ DUAL AGONISM AND MITOCHONDRIAL PYRUVATE CARRIER INHIBITION 23
Novel Phenothiazine/Donepezil-Like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease 22
Food Industry Byproducts as Starting Material for Innovative, Green Feed Formulation: A Sustainable Alternative for Poultry Feeding 22
Multi-Target Approach for the Design of New Compounds Potentially Useful for the Prevention and Treatment of Cardiovascular and/or Neurodegenerative Diseases 22
A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition 20
Peroxisome Proliferator Activated Receptor (PPAR) agonists as Fatty Acid Amide Hydrolase (FAAH) inhibitors: screening and preliminary structure-activity relationships 20
IDENTIFICATION OF A NOVEL PPARRα/γ DUAL AGONIST SHOWING ANTIDIABETIC EFFECTS AND ABLE TO BIND TO CANONICAL AND ALLOSTERIC SITES OF ABLE TO BIND TO CANONICAL AND ALLOSTERIC SITES OF PPARγ 19
Rivastigmine-based hybrids: a multi-target approach to anti-Alzheimer’s drug design 18
A Chemical Modification of a Peroxisome Proliferator-Activated Receptor Pan Agonist Produced a Shift to a New Dual Alpha/Gamma Partial Agonist Endowed with Mitochondrial Pyruvate Carrier Inhibition and Antidiabetic Properties 17
New rivastigmine-like compounds for the potential treatment of Alzheimer’s disease: a multi-target approach 16
Development of N-(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase 15
FPR2 and brimstone: a novel approach for the treatment of neuroinflammation 14
The pivotal role of pyrrolidine ring as multitarget scaffold in neurodegenerative diseases 13
Green Methods to Recover Bioactive Compounds from Food Industry Waste: A Sustainable Practice from the Perspective of the Circular Economy 13
Role of copper chelating agents: between old applications and new perspectives in neuroscience 13
New phenothiazine-donepezil like hybrids as potential Alzheimer’s disease multitarget drugs with antioxidant properties 10
Novel rivastigmine structure-based hybrids for the potential treatment of Alzheimer’s disease 10
Allosteric Modulators of Serotonin Receptors: A Medicinal Chemistry Survey 9
From classical MTDLs to a semi-synthetic innovative green approach: nature-inspired design as a new intriguing opportunity for new anti-Alzheimer’s drugs 8
Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer’s drug candidates 8
Multitarget 5-HT6R/FAAH/ChE ligands: the future of Alzheimer’s Disease treatment? 7
Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases 7
Novel Rivastigmine-Based Multitarget Hybrids For Potential Treatment of Alzheimer’s Disease: Cu(II) And Fe(III) Chelation Studies 6
Discovery of a dual PPARα/γ partial agonist displaying antisteatotic and antidiabetic properties: in silico studies and X-ray structure determination 5
Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease 3
Rivastigmine-Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases 2
Totale 1.476
Categoria #
all - tutte 9.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.210


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020101 0 0 0 0 6 6 18 17 18 18 13 5
2020/2021233 30 5 8 47 1 6 42 13 11 45 12 13
2021/2022152 10 6 2 1 0 13 3 5 13 14 26 59
2022/2023418 33 61 36 33 32 52 7 57 68 9 19 11
2023/2024241 14 22 15 12 21 56 12 2 17 23 17 30
2024/2025306 79 42 70 63 52 0 0 0 0 0 0 0
Totale 1.476